FLAMeS, a new convolutional neural network, enhances MS lesion segmentation accuracy using only T2-weighted FLAIR images, ...
AUSTIN, Texas and TOKYO, Dec. 17, 2025 /PRNewswire/ -- According to DataM Intelligence, the global Disease-Modifying Therapies (DMTs) Market was valued at USD 65.32 billion in 2024 and is projected to ...
In the world of medical devices, all companies are trying to fulfill unmet needs, but only a chosen few will differentiate ...
Third are sensory reconstruction interfaces, such as restoring hearing or vision. For patients who have lost sensory input, ...
NetraMark Holdings Inc. (the "Company" or "NetraMark") a premier artificial intelligence (AI) company that is transforming clinical trials with AI powered precision analytics in the pharmaceutical ...
Zacks Investment Research on MSN
BD and Penn Institute ink collaboration to advance immunotherapy
Becton, Dickinson and Company BDX, popularly known as BD, recently announced a collaboration with the Institute for ...
According to DataM Intelligence, the global Disease-Modifying Therapies (DMTs) Market was valued at USD 65.32 billion in 2024 and is projected ...
Multiple sequence alignment (MSA) is a cornerstone of computational biology, facilitating the exploration of functional, structural and evolutionary relationships among biological sequences.
Organoid Intelligence (OI) represents a groundbreaking convergence of biology and technology, aiming to redefine biocomputing using brain organoids—three-dimensional neural structures derived from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback